Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Target Site Pharmacokinetics of Doripenem at Steady State in Intubated Intensive Care Patients

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2011 by Medical University of Vienna.
Recruitment status was:  Recruiting
Sponsor:
Information provided by (Responsible Party):
Markus Zeitlinger, Medical University of Vienna
ClinicalTrials.gov Identifier:
NCT01414959
First received: August 10, 2011
Last updated: September 5, 2011
Last verified: September 2011

August 10, 2011
September 5, 2011
August 2011
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT01414959 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Target Site Pharmacokinetics of Doripenem at Steady State in Intubated Intensive Care Patients
Target Site Pharmacokinetics of Doripenem at Steady State in Intubated Intensive Care Patients
The investigators will measure the pharmacokinetics of doripenem in skeletal muscle, subcutaneous adipose tissue, bronchoalveolar lavage and plasma of intubated intensive care patients.
Methods: microdialysis, blood sampling, bronchoalveolar lavage
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples Without DNA
Description:
plasma broncheoalvoeolar lavage microdialysates
Non-Probability Sample
intubated patients, intensive care
  • Pneumonia
  • Abdominal Infection
  • Urinary Tract Infection
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
16
July 2013
Not Provided

Inclusion Criteria:

  • endotracheal intubation; pneumonia or complicated abdominal infection or complicated urinary tract infection

Exclusion Criteria:

  • allergy to doripenem, hemodialysis
Both
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Austria
 
NCT01414959
Dori_MD_ICU
No
Not Provided
Not Provided
Markus Zeitlinger, Medical University of Vienna
Medical University of Vienna
Not Provided
Principal Investigator: Markus Zeitlinger, MD Medical Universit of Vienna
Medical University of Vienna
September 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP